FDA Approval Activities for this Drug…

AVAGE (tazarotene) Cream, 0.1%, Allergan, NDA 21-184/S-002 Tazorac (tazarotene) Cream, 0.05% & 0.1%, Allergan NDA 21-184 9/29/00 10/10/00 10/16/00 Tazorac (tazarotene) Cream, 0.1%, Allergan NDA 21-184/S1 10/24/01 11/6/01 11/6/01 12/12/01 Indication: Treatment for Plaque Psoriasis. Tazorac (tazarotene) Gel, Allergan

For the latest approval information, please see the main page.